Building a Prospective Upper-Limb Outcomes Registry

Status

Ongoing — registry infrastructure and enrolment underway.

Why a registry, rather than individual studies

Most orthopaedic evidence comes from individual case series or trials, each set up and torn down separately. A prospective registry instead collects standardised data continuously across routine practice, which means it can answer questions that weren't anticipated when data collection began — genuinely rare complications, long-term trends, or subgroup patterns that a single study would be underpowered to detect.

What's being collected

• Baseline data: diagnosis, relevant imaging findings, and baseline patient-reported outcome scores (see our related article on standardising PROMs in upper-limb practice) before treatment
• Procedure data: intervention performed, fixation or implant details, and any intra-operative findings relevant to outcome
• Follow-up data: structured PROM collection at fixed intervals, complication and reoperation tracking, and — where applicable — objective motion or strength data from remote-monitoring tools
• Long-term tracking: continued follow-up beyond the typical 1-year study endpoint, where feasible, to capture outcomes that only become apparent over several years (implant longevity, late stiffness, arthritis progression)

Data governance

All registry data is collected with informed patient consent, stored in de-identified form for analysis, and handled under a defined data-governance protocol. Identifiable data is never shared outside the clinical team without separate explicit consent for a specific research use.

What we hope this enables

• More reliable, practice-specific benchmarks than relying solely on published series from other populations and settings
• A foundation for the outcome-prediction modelling work described in our research agenda
• The ability to detect an emerging pattern — a higher-than-expected complication rate with a specific technique, for instance — earlier than a series of disconnected retrospective reviews would allow

Participation

Colleagues interested in a shared, multi-centre registry structure, or wanting to discuss our data schema and governance approach, are welcome to get in touch via the Contact page.